Heart Failure and Transplant

Ventricular Assist Device Implantation

Ventricular Assist Device Implantation: Volume

2017 – 2022

Since 1989, Cleveland Clinic has been using ventricular assist devices to treat patients with advanced heart failure. These devices are used in both patients who are waiting for a heart transplant (bridge-to-transplant) and in patients who are not transplant candidates (destination therapy). Cleveland Clinic uses the latest available technology to deliver excellent outcomes.

LVAD = left ventricular assist device

Cleveland Clinic surgeons implanted 72 LVADs in 2022.

Continuous Flow Left Ventricular Assist Device: Postimplant Survival

June 2006 – March 2023

The Society of Thoracic Surgeons (STS) Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) is a national registry for patients with mechanical circulatory support devices. Compared to national averages, the survival rates for Cleveland Clinic LVAD (left ventricular assist device) patients are better than expected at 1 year, 3 years, and 4 years after implant.

INTERMACS = Interagency Registry for Mechanically Assisted Circulatory Support

Intermacs Report June 23, 2006 to March 31, 2023.